An observational study in Sepsis, sponsored by Second Affiliated Hospital of Wenzhou Medical University. Completed at 2 sites in China. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-10-31.
Sponsored by Second Affiliated Hospital of Wenzhou Medical University · Observational
The aim of this study is to identify risk factors associated with sepsis and to construct a predictive model for sepsis. This will provide an objective theoretical and empirical foundation for the diagnosis, assessment, and management of sepsis in our country.The primary questions addressed are:
What are the risk factors for the development of sepsis? How do we improve the prognosis of sepsis?
1,899 studies on the registry are indexed under Sepsis; 462 are open to participants now.
This study's enrollment of 1,000 is above the median of 160 across 931 observational studies indexed under Sepsis.
Browse Sepsis studies →Second Affiliated Hospital of Wenzhou Medical University is the lead sponsor of 133 studies on the registry; 44 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Patients with Infection or Suspected Infection
Exclusion Criteria:
Other: Tumor Necrosis Factor · Other: Interleukin-1β · Other: Interleukin-12 · Other: Interleukin-18 · Other: Complement C3 · Other: Complement C5
Other: Tumor Necrosis Factor · Other: Interleukin-1β · Other: Interleukin-12 · Other: Interleukin-18 · Other: Complement C3 · Other: Complement C5
This study is a retrospective observational study, with Tumor Necrosis Factor being one of the exposure factors under investigation.
This study is a retrospective observational study, with Interleukin-1β being one of the exposure factors under investigation.
This study is a retrospective observational study, with Interleukin-12 being one of the exposure factors under investigation.
This study is a retrospective observational study, with Interleukin-18 being one of the exposure factors under investigation.
This study is a retrospective observational study, with Complement C3 being one of the exposure factors under investigation.
This study is a retrospective observational study, with Complement C5 being one of the exposure factors under investigation.
Sepsis
A rapid increase of 2 or more points points in the Sequential Organ Failure Assessment (SOFA) score after patient infection.SOFA score, which ranges from a minimum of 2 to a maximum of 15, indicates a worse outcome with higher scores.
Time frame: 3 months
This study is completed, as verified in Oct 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Second Affiliated Hospital of Wenzhou Medical University